These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2109595)

  • 1. Suppression of tumor promotion by inhibitors of poly(ADP)ribose formation.
    Troll W; Garte S; Frenkel K
    Basic Life Sci; 1990; 52():225-32. PubMed ID: 2109595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease inhibitors interfere with the necessary factors of carcinogenesis.
    Troll W
    Environ Health Perspect; 1989 May; 81():59-62. PubMed ID: 2667986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of cancer by agents that suppress oxygen radical formation.
    Troll W
    Free Radic Res Commun; 1991; 12-13 Pt 2():751-7. PubMed ID: 2060847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of tumorigenesis of oncogene-transformed rat fibroblasts with DNA site inhibitors of poly(ADP ribose) polymerase.
    Tseng A; Lee WM; Jakobovits EB; Kirsten E; Hakam A; McLick J; Buki K; Kun E
    Proc Natl Acad Sci U S A; 1987 Feb; 84(4):1107-11. PubMed ID: 3103126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Free oxygen radicals: necessary contributors to tumor promotion and cocarcinogenesis.
    Troll W; Frenkel K; Teebor G
    Princess Takamatsu Symp; 1983; 14():207-18. PubMed ID: 6394590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poly(ADP-ribose) synthesis is involved in the toxic effects of alkylating agents but does not regulate DNA repair.
    Cleaver JE; Morgan WF
    Mutat Res; 1985; 150(1-2):69-76. PubMed ID: 3923344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonistic action of a tumor promoter and a poly(adenosine diphosphoribose) synthesis inhibitor in radiation-induced transformation in vitro.
    Borek C; Cleaver JE
    Biochem Biophys Res Commun; 1986 Feb; 134(3):1334-41. PubMed ID: 3947368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(ADP-ribose) and the response of cells to ionizing radiation.
    Oleinick NL; Evans HH
    Radiat Res; 1985 Jan; 101(1):29-46. PubMed ID: 3918331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteome-wide identification of poly(ADP-ribose) binding proteins and poly(ADP-ribose)-associated protein complexes.
    Gagné JP; Isabelle M; Lo KS; Bourassa S; Hendzel MJ; Dawson VL; Dawson TM; Poirier GG
    Nucleic Acids Res; 2008 Dec; 36(22):6959-76. PubMed ID: 18981049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study on the effect of tumor promoters on poly ADP-ribosylation in A431 cells.
    Singh N
    Int J Cancer; 1990 Oct; 46(4):648-52. PubMed ID: 2120135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear incorporation of [adenine 14C]NAD is altered by compounds which affect poly(ADP-ribose) formation.
    Tramontano WA; Phillips DA; Carman CA; Massaro AM
    Phytochemistry; 1990; 29(1):31-3. PubMed ID: 1367419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting and Quantifying pADPr In Vivo.
    Lai YC; Aneja RK; Satchell MA; Clark RSB
    Methods Mol Biol; 2017; 1608():27-43. PubMed ID: 28695501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical alterations in inflammatory periodontal diseases I. Poly (ADP-ribose) synthetase activity in gingiva and gingival fibroblasts from humans with periodontitis.
    Ghani QP; Armitage GC; Hussain MZ
    J Periodontal Res; 1996 Oct; 31(7):445-52. PubMed ID: 8915946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of amplified genes by poly(ADP-ribose) polymerase inhibitors.
    Nagao M; Nakayasu M; Aonuma S; Shima H; Sugimura T
    Environ Health Perspect; 1991 Jun; 93():169-74. PubMed ID: 1773788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some protease inhibitors are also inhibitors of poly(ADP-ribose) polymerase.
    Cleaver JE; Banda MJ; Troll W; Borek C
    Carcinogenesis; 1986 Feb; 7(2):323-5. PubMed ID: 3081273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of poly(ADP-ribose) polymerase modulates tumor-related gene expression, including hypoxia-inducible factor-1 activation, during skin carcinogenesis.
    Martin-Oliva D; Aguilar-Quesada R; O'valle F; Muñoz-Gámez JA; Martínez-Romero R; García Del Moral R; Ruiz de Almodóvar JM; Villuendas R; Piris MA; Oliver FJ
    Cancer Res; 2006 Jun; 66(11):5744-56. PubMed ID: 16740713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting and quantifying pADPr in vivo.
    Lai YC; Aneja RK; Satchell MA; Clark RS
    Methods Mol Biol; 2011; 780():117-34. PubMed ID: 21870258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of poly(adenosine diphosphate-ribose) synthesis: effect on other metabolic processes.
    Milam KM; Cleaver JE
    Science; 1984 Feb; 223(4636):589-91. PubMed ID: 6420886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor promoter phorbol-12-myristate-13-acetate induces poly ADP-ribosylation in human monocytes.
    Singh N; Poirier G; Cerutti P
    Biochem Biophys Res Commun; 1985 Feb; 126(3):1208-14. PubMed ID: 2983703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of poly(ADP-ribosyl)ation does not prevent lymphocyte entry into the cell cycle.
    Marini M; Zunica G; Monti D; Cossarizza A; Ortolani C; Franceschi C
    FEBS Lett; 1989 Aug; 253(1-2):146-50. PubMed ID: 2527165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.